EGFR and neoplasm: EGFR amplification and PTEN deletion were more prevalent in TCGA (49.6%/35.6%, respectively) compared to IRCR cohort (32%/26.3%), suggesting that IRCR tumors may undergo alternative molecular pathways during tumor propagation.